Deltagen Inc. (DGEN)

0.0000 0.0000 (0.00%) As of 03:48PM EDT. Market open.

Deltagen Inc.

1900 South Norfolk Street
Suite 105
San Mateo, CA 94403
United States
650-345-7601
https://www.deltagen.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Robert J. Driscoll	CEO, President, Secretary & Director	411k	N/A	1966
Mr. Daniel Ratto	Chief Financial Officer	105.3k	N/A	1958

Amounts are as of 31 December 2006, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.

Corporate governance

Deltagen Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.